Mycofenolsýra Accord (Mycofenolsýra Accord Healthcare) Magasýruþolin tafla 180 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

mycofenolsýra accord (mycofenolsýra accord healthcare) magasýruþolin tafla 180 mg

accord healthcare b.v. - mycophenolatum natríum - magasýruþolin tafla - 180 mg

Mycofenolsýra Accord (Mycofenolsýra Accord Healthcare) Magasýruþolin tafla 360 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

mycofenolsýra accord (mycofenolsýra accord healthcare) magasýruþolin tafla 360 mg

accord healthcare b.v. - mycophenolatum natríum - magasýruþolin tafla - 360 mg

Myfortic Magasýruþolin tafla 180 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

myfortic magasýruþolin tafla 180 mg

novartis healthcare a/s - mycophenolatum natríum - magasýruþolin tafla - 180 mg

Myfortic Magasýruþolin tafla 360 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

myfortic magasýruþolin tafla 360 mg

novartis healthcare a/s - mycophenolatum natríum - magasýruþolin tafla - 360 mg

Mykofenolatmofetil Actavis Filmuhúðuð tafla 500 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

mykofenolatmofetil actavis filmuhúðuð tafla 500 mg

actavis group ptc ehf. - mycophenolatum mofetil - filmuhúðuð tafla - 500 mg

Akeega Evrópusambandið - íslenska - EMA (European Medicines Agency)

akeega

janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - stækkun Æxli, gelding-Þola - Æxlishemjandi lyf - treatment of adult patients with prostate cancer.

Columvi Evrópusambandið - íslenska - EMA (European Medicines Agency)

columvi

roche registration gmbh  - glofitamab - lymphoma, large b-cell, diffuse - Æxlishemjandi lyf - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.

Talvey Evrópusambandið - íslenska - EMA (European Medicines Agency)

talvey

janssen-cilag international n.v. - talquetamab - mergæxli - Æxlishemjandi lyf - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

Litfulo Evrópusambandið - íslenska - EMA (European Medicines Agency)

litfulo

pfizer europe ma eeig - ritlecitinib tosilate - alopecia areata - Ónæmisbælandi lyf - litfulo is indicated for the treatment of severe alopecia areata in adults and adolescents 12 years of age and older.

Jaypirca Evrópusambandið - íslenska - EMA (European Medicines Agency)

jaypirca

eli lilly nederland b.v. - pirtobrutinib - eitilfrumukrabbamein, mantle-cell - prótín nt-hemlar - treatment of mantle cell lymphoma (mcl).